{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:59:27Z","timestamp":1768640367431,"version":"3.49.0"},"reference-count":83,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.1080\/21645515.2020.1855952","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T10:50:11Z","timestamp":1613818211000},"page":"2205-2215","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines"],"prefix":"10.1080","volume":"17","author":[{"given":"Lidia","family":"Serra","sequence":"first","affiliation":[{"name":"Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Knuf","sequence":"additional","affiliation":[{"name":"Dr. Horst Schmidt Clinic, Children\u2019s Hospital, Wiesbaden, Germany, and Pediatric Infectious Diseases, University Medicine, Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-581X","authenticated-orcid":false,"given":"Federico","family":"Martin\u00f3n-Torres","sequence":"additional","affiliation":[{"name":"Pediatrics Department, Translational Pediatrics and Infectious Diseases, Hospital Cl\u00ednico Universitario de Santiago de Compostela, Santiago de Compostela, Spain"},{"name":"Genetics, Vaccines and Pediatrics Research Group, University of Santiago de Compostela, Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Yi","sequence":"additional","affiliation":[{"name":"Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[{"name":"Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Ltd, Tadworth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"European Centre for Disease Prevention and Control. Fact sheet about meningococcal disease. [accessed 2020 January 13] https:\/\/www.ecdc.europa.eu\/en\/meningococcal-disease\/factsheet."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819002152"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"e_1_3_3_6_1","article-title":"Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","author":"Cohn AC","unstructured":"Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meer HC, Baker CJ, Messonnier NE, Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. [accessed 2020 July 2]. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6202a1.htm","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_7_1","unstructured":"World Health Organization. Immunization standards: meningococcal A conjugate 10 dose presentation. World Health Organization. [accessed 2020 May 28] https:\/\/www.who.int\/immunization_standards\/vaccine_quality\/PQ_197_MenAconjugate_10dose_SII\/en\/"},{"key":"e_1_3_3_8_1","unstructured":"MenAfriVac (meningococcal A conjugate vaccine). Full Prescribing Information. Pune (India): Serum Institute of India; 2015."},{"key":"e_1_3_3_9_1","unstructured":"Menjugate 10 micrograms suspension for injection (Meningococcal group C conjugate vaccine). Summary of Product Characteristics Siena (Italy): GSK Vaccines S.r.l.; 2018."},{"key":"e_1_3_3_10_1","volume-title":"Full Prescribing Information","author":"Meningitec (meningococcal serogroup C conjugate vaccine)","year":"2011","unstructured":"Meningitec (meningococcal serogroup C conjugate vaccine). Full Prescribing Information. West Ryde (NSW, Australia): Pfizer Australia Pty Ltd; 2011."},{"issue":"64","key":"e_1_3_3_11_1","first-page":"43","article-title":"Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months","volume":"12","year":"2003","unstructured":"Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months. Prescrire Int. 2003;12(64):43\u201346.","journal-title":"Prescrire Int"},{"key":"e_1_3_3_12_1","volume-title":"Summary of Product Characteristics","author":"NeisVac-C (Meningococcal Group C Polysaccharide Conjugate Vaccine Adsorbed)","year":"2019","unstructured":"NeisVac-C (Meningococcal Group C Polysaccharide Conjugate Vaccine Adsorbed). Summary of Product Characteristics. Sandwich (Kent, UK): Pfizer Limited; 2019."},{"key":"e_1_3_3_13_1","volume-title":"Summary of Product Characteristics","author":"Bexsero (Meningococcal group B Vaccine [rDNA, component, adsorbed])","year":"2019","unstructured":"Bexsero (Meningococcal group B Vaccine [rDNA, component, adsorbed]). Summary of Product Characteristics. Uxbridge (Middlesex, UK): GlaxoSmithKline UK; 2019."},{"key":"e_1_3_3_14_1","volume-title":"Summary of Product Characteristics","author":"Trumenba (MenB-FHbp)","year":"2018","unstructured":"Trumenba (MenB-FHbp). Summary of Product Characteristics. Sandwich (Kent, UK): Pfizer Ltd; 2018."},{"key":"e_1_3_3_15_1","volume-title":"Full Prescribing Information","author":"MENHIBRIX (Hib-MenCY-TT)","year":"2013","unstructured":"MENHIBRIX (Hib-MenCY-TT). Full Prescribing Information. Rixensart (Belgium): GlaxoSmithKline; 2013."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-019-00275-4"},{"key":"e_1_3_3_17_1","volume-title":"Summary of Product Characteristics","author":"NIMENRIX","year":"2020","unstructured":"NIMENRIX. Summary of Product Characteristics. Sandwich (Kent, UK): Pfizer Limited; 2020."},{"key":"e_1_3_3_18_1","volume-title":"Summary of Product Characteristics. Sovicille (Italy): GSK vaccines S.r.l.","author":"Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine)","year":"2014","unstructured":"Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine). Summary of Product Characteristics. Sovicille (Italy): GSK vaccines S.r.l.; 2014."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6832a3"},{"key":"e_1_3_3_20_1","volume-title":"Full Prescribing Information","author":"MenQuadfi (MenACWY-TT)","year":"2020","unstructured":"MenQuadfi (MenACWY-TT). Full Prescribing Information. Swiftwater (PA): Sanofi Pasteur Inc; 2020."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103571"},{"key":"e_1_3_3_22_1","unstructured":"European Centre for Disease Prevention and Control. Prevention and control measures for meningococcal disease. [accessed 2020 April 3] https:\/\/www.ecdc.europa.eu\/en\/meningococcal-disease\/prevention-and-control"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S159952"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6010012"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.04.012"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901229"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1745070"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.007"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00053.x"},{"key":"e_1_3_3_31_1","unstructured":"European Centre for Disease Prevention and Control. Disease data from ECDC surveillance atlas for meningococcal disease. [accessed 2019 March 20] https:\/\/ecdc.europa.eu\/en\/meningococcal-disease\/surveillance-and-disease-data\/atlas."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1532248"},{"key":"e_1_3_3_33_1","volume-title":"Paper presented at: 15th Congress of the","author":"Skoczynska A","year":"2019","unstructured":"Skoczynska A, Wasko I, Kuch A, Ronkiewicz P, Golebiewska A, Wrobel I, Kiedrowska M, Hryniewicz W Invasive Meningococcal disease in Poland [PO-004-13211]. Paper presented at: 15th Congress of the, European Meninogococcal and Haemophilus Disease Society; 2019 May 27-30;Lisbon (Portugal)."},{"key":"e_1_3_3_34_1","volume-title":"Paper presented at: 15th Congress of the EMGM","author":"Wasko I","year":"2019","unstructured":"Wasko I, Golebiewska A, Kiedrowska M, Ronkiewicz P, Wrobel I, Kuch A, Skoczynska A. Emerging meningococci representing ST-9316 in Poland. Paper presented at: 15th Congress of the EMGM European Meninogococcal and Haemophilus Disease Society; 2019 May 27- 30; Lisbon (Portugal)."},{"key":"e_1_3_3_35_1","volume-title":"Current status of serogroup W meningococcal disease in Poland [OC-13214]. Paper presented at: 15th Congress of the European Meninogococcal and Haemophilus Disease Society","author":"Reinsert Skoczynska A, Wasko I, Kuch A, Ronkiewicz P, Golebiewska A, Wrobel I, Kiedrowska M, Hryniewicz W","year":"2019","unstructured":"Reinsert Skoczynska A, Wasko I, Kuch A, Ronkiewicz P, Golebiewska A, Wrobel I, Kiedrowska M, Hryniewicz W. Current status of serogroup W meningococcal disease in Poland [OC-13214]. Paper presented at: 15th Congress of the European Meninogococcal and Haemophilus Disease Society; 2019 May 27-30; Lisbon, Portugal."},{"key":"e_1_3_3_36_1","unstructured":"Skoczynska A Wasko I Kuch A Ronkiewicz P Golebiewska A Wrobel I Kiedrowska M Hryniewicz W. Current status of serogroup W meningococcal disease in Poland [OC-13214]. Paper presented at: 15th Congress of the European Meninogococcal and Haemophilus Disease Society: 2019 May 27\u201330; Lisbon Portugal."},{"key":"e_1_3_3_37_1","volume-title":"Paper presented at: 15th Congress of the EMGM","author":"Deghmane A","year":"2019","unstructured":"Deghmane A, Hong E, Taha M-K The emergence of a new genetic lineage (ST-9316) of Neisseria meningitidis serogroup W in North France. Paper presented at: 15th Congress of the EMGM, European Meninogococcal and Haemophilus Disease Society; 2019 May 27-30; Lisbon, Portugal."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2015.20.45.30061"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1051276"},{"key":"e_1_3_3_40_1","unstructured":"Public Health England. Meningococcal ACWY conjugate vaccination (MenACWY). [accessed 2020 July 2] https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/437901\/150622_ACWY_bipartite_letter.pdf."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.16.18-00158"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.011"},{"key":"e_1_3_3_43_1","volume-title":"Piano Nazionale Prevenzione Vaccinale: PNPV 2017-2019","author":"Ministero della Salute Italia","year":"2017","unstructured":"Ministero della Salute Italia. Piano Nazionale Prevenzione Vaccinale: PNPV 2017-2019. Rome (Italy): Ministero della Salute Italia; 2017."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-019-0254-1"},{"key":"e_1_3_3_45_1","unstructured":"Health Protection Surveillance Centre. Bacterial Meningitis\/Meningococcal disease. [accessed 2020 March 12] http:\/\/www.hse.ie\/eng."},{"key":"e_1_3_3_46_1","unstructured":"Spanish Ministry of Health. Recomendaciones de vacunaci\u00f3n frente a la enfermedad meningoc\u00f3cica invasiva. [accessed 2019 July 12] https:\/\/www.mscbs.gob.es\/en\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/Recomendaciones_Vacunacion_Meningococo.pdf."},{"key":"e_1_3_3_47_1","unstructured":"Leon JDCY. Actualizaci\u00f3n del calendario de vacunaci\u00f3n infantil 2019 vacunaci\u00f3n frente a meningococo. 2018."},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.159"},{"key":"e_1_3_3_49_1","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 global summary. [accessed 2019 October 15] http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules."},{"key":"e_1_3_3_50_1","unstructured":"Superior Health Council Belgium. Advisory 9485 meningococcal vaccination. [accessed 2020 January 28] https:\/\/www.health.belgium.be\/nl\/advies-9485-vaccinatie-tegen-meningokokken."},{"key":"e_1_3_3_51_1","first-page":"1521","article-title":"[Update of the 2019 Swiss immunization schedule 7 new recommendations and review of practical implications for health professionals]","volume":"15","author":"Diana A","year":"2019","unstructured":"Diana A, Iten A, Landry P, Bouvier Gallacchi M. [Update of the 2019 Swiss immunization schedule 7 new recommendations and review of practical implications for health professionals]. Rev Med Suisse. 2019;15:1521\u201325.","journal-title":"Rev Med Suisse"},{"key":"e_1_3_3_52_1","unstructured":"Federal Ministry of Health (Austria). Impfplan \u00d6sterreich 2012."},{"key":"e_1_3_3_53_1","unstructured":"ECDC Vaccine Scheduler. Vaccine schedules in all countries in the European Union. Czech Republic: Recommended vaccinations. [accessed 2020 May 27] https:\/\/vaccine-schedule.ecdc.europa.eu\/."},{"key":"e_1_3_3_54_1","unstructured":"Ministers Department of Health. Quad-strain meningococcal vaccine to be added to national immunisation program. [accessed 2019 June 3] http:\/\/www.health.gov.au\/internet\/ministers\/publishing.nsf\/Content\/97678EE0888F2877CA258227007CCBFF\/$File\/GH016.pdf."},{"key":"e_1_3_3_55_1","unstructured":"Australian Government Department of Health. National immunisation program. [accessed 2020 May 27] https:\/\/www.health.gov.au\/initiatives-and-programs\/national-immunisation-program."},{"key":"e_1_3_3_56_1","volume-title":"Immunisation Handbook","author":"New Zealand Ministry of Health","year":"2017","unstructured":"New Zealand Ministry of Health. Immunisation Handbook. 2017. 2nd March 2018. Wellington, New Zealand: Ministry of Health. 2018.","edition":"2"},{"key":"e_1_3_3_57_1","unstructured":"New Zealand Ministry of Health. Meningococcal vaccines: eligibility recommendations and supply. [accessed 2020 May 27] https:\/\/www.health.govt.nz\/our-work\/diseases-and-conditions\/meningococcal\/meningococcal-vaccines-eligibility-recommendations-and-supply."},{"key":"e_1_3_3_58_1","unstructured":"Ministerio de Salud (Republica Argentina). Fundamentos de la introducci\u00f3n de la vacuna tetravalente (ACYW) conjugada contra meningococo al Calendario Nacional de Inmunizaciones. [accessed 2019 June 3] http:\/\/www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000000927cnt-2016-12_lineamientos-meningo.pdf."},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/16.8.485"},{"key":"e_1_3_3_60_1","unstructured":"Government of Canada. Provincial and territorial routine and catch-up vaccination schedule for infants and children in Canada. [accessed 2020 May 27] https:\/\/www.canada.ca\/en\/public-health\/services\/provincial-territorial-immunization-information\/provincial-territorial-routine-vaccination-programs-infants-children.html."},{"key":"e_1_3_3_61_1","unstructured":"Government of Malta. National immunisation schedule (Immunisation schedule for ages 0-16 years). [accessed 2020 July 21] https:\/\/deputyprimeminister.gov.mt\/en\/phc\/pchyhi\/Pages\/National-Immunisation-Schedule.aspx."},{"key":"e_1_3_3_62_1","unstructured":"Programa Nacional de Imuniza\u00e7\u00f5es. Informe T\u00e9cnico. Orienta\u00e7\u00f5es t\u00e9cnico-operacionais para a Vacina\u00e7\u00e3o dos Adolescentes com a Vacina Meningoc\u00f3cica ACWY (conjugada). 2020."},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001484"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.043"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.064"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.009"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1924-0"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000897"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.007"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22166"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1568-1573.2001"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.068"},{"key":"e_1_3_3_76_1","unstructured":"European Medicines Agency. Assessment report: Nimenrix. [accessed 2018 October 23] https:\/\/www.ema.europa.eu\/documents\/assessment-report\/nimenrix-epar-public-assessment-report_en.pdf."},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2307.170236"},{"key":"e_1_3_3_78_1","first-page":"18","volume-title":"Paper presented at: 14th Congress of the EMGM, European Meninogococcal and Haemophilus Disease Society","author":"Villena R","year":"2017","unstructured":"Villena R, Santolaya ME. Chilean experience with serogroup W outbreak and meningococcal ACWY conjugate vaccines. Paper presented at: 14th Congress of the EMGM, European Meninogococcal and Haemophilus Disease Society; 2017 September 18\u201321;Prague, Czech Republic."},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trivac.2014.06.003"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.013"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.046"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.4.2.156-167.1997"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.030"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1746110"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1855952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:58:28Z","timestamp":1709305108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1855952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,3]]}},"alternative-id":["10.1080\/21645515.2020.1855952"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1855952","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}